ArticleAmerican journal of ophthalmology2013
Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases.
Article in American journal of ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 69 citations in OpenAlex.
- Vasoproliferative Tumors of the Retina: Pathophysiology, Clinical Features, and Treatment Approaches.Ocular oncology and pathology · 2026Article
- Vasoproliferative Retinal Tumor with Hemangioblastoma-like Features: Evaluation with von Wilebrand Factor.Journal of clinical medicine · 2026Article
- Outcomes of Vitrectomy for Macular Pathologies Associated with Idiopathic Vasoproliferative Retinal Tumor.Journal of clinical medicine · 2025Article
- Vitrectomy and tumor endoresection for the diagnosis and treatment of focal nodular retinal gliosis.Digital journal of ophthalmology : DJO · 2023Article
- Pseudoangiomatous retinal gliosis (PARG) treated with iodine plaque in patient with chronic retinal detachment.American journal of ophthalmology case reports · 2022Article
- Management of Vasoproliferative Tumors of the Retina with Macular Complications by Pars Plana Vitrectomy Combined with Episcleral Cryotherapy.Journal of ophthalmology · 2021Article
- Optic nerve head reactive retinal astrocytic tumor treated with photodynamic therapy.American journal of ophthalmology case reports · 2020Article
- Reactivation of Retinopathy of Prematurity in Adults and Adolescents.Ophthalmology. Retina · 2020Article
- Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors.Journal of ophthalmology · 2019Article
- Retinal vasoproliferative tumor - A proposal for classification.Indian journal of ophthalmology · 2018Article
- Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants.Indian journal of ophthalmology · 2018Article
- Episcleral brachytherapy as an effective alternative in vasoproliferative tumors.International journal of ophthalmology · 2018Article
- Reactive Retinal Astrocytic Tumor (Focal Nodular Gliosis): Report of the Clinical Spectrum of 3 Cases.Ocular oncology and pathology · 2017Article
- Retinal Reactive Astrocytic Tumor (Focal Nodular Gliosis): The Entity Also Known as Vasoproliferative Tumor.Ocular oncology and pathology · 2017Article
- Reactive Retinal Astrocytic Tumor (Focal Nodular Gliosis): A Case Report.Ocular oncology and pathology · 2017Article
- Proliferative Vitreoretinopathy in Treated Retinoblastoma.Ophthalmology. RetinaArticle
- CyberKnife Stereotactic Radiotherapy in Secondary Vasoproliferative Tumor of the Retina.Case reports in ophthalmologyArticle
- Large Vasoproliferative Retinal Tumor Refractory to Cryotherapy Treated with Salvage I-125 Plaque Radiation Therapy.Advances in radiation oncologyArticle
- Bilateral Vasoproliferative Tumors in Usher Syndrome.Case reports in ophthalmologyArticle
- Clinical characters and treatments of retinal vasoproliferative tumors.Taiwan journal of ophthalmologyArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
8 authors at 5 institutions in 2 countries.
Funding
Abstract
purposeTo evaluate the cellular nature of and diagnostic terminology used in connection with acquired retinal "vasoproliferative tumors."
designRetrospective clinicopathologic study.
methodsClinical records and microscopic slides of 4 enucleated globes were reviewed. Special stains and immunohistochemical probes for CD31, CD34, p53, glial fibrillary acidic protein (GFAP), CD163, and Ki67 (cell replication) were employed; ultrastructural and fluorescence in situ hybridization (FISH) analyses were performed.
resultsTumors were located inferotemporally in middle-aged patients. They were uniformly composed of compacted elongated, GFAP-positive spindle cells (due to intermediate filaments identified ultrastructurally) with a Ki67 index of less than 1%. Rosenthal fibers and eosinophilic granular bodies were observed. Hyalinized periodic acid-Schiff-positive vessels were widely separated. CD31 and CD34 revealed a sparse microvasculature. Tumor-associated exudate spread predominantly subretinally. The retinal pigment epithelium had undergone extensive placoid fibrous metaplasia with focal ossification. P53 upregulation, BRAF-KIAA gene rearrangement, and IDH1R132H mutation typically associated with low-grade astrocytic neoplasms were absent.
conclusionsRetinal "vasoproliferative" tumors have been mischaracterized, because they actually display a paucity of microvessels. Proliferating fibrous astrocytes with a very low proliferation index predominate, without immunohistochemical or genetic evidence favoring a neoplasm. Subretinal exudate appeared capable of provoking widespread fibrous metaplasia of the pigment epithelium that was mainly responsible for secondary retinal damage. The term "reactive retinal astrocytic tumor" is proposed as more appropriate for this entity. In carefully selected progressive lesions, consideration should be given to earlier surgical intervention before extensive subretinal exudate accumulates and pigment epithelial proliferation with fibrous metaplasia ensues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.